Induction of transforming growth factor beta receptors following focal ischemia in the rat brain

PLoS ONE

Volumn 9, Issue 9, 2014, Pages

  Pál, Gabriella ^a   Lovas, Gábor ^b,c   Dobolyi, Arpád ^a,d  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b SEMMELWEIS UNIVERSITY OF MEDICINE   (Hungary)

^c Jahn Ferenc Del Pesti korhaz Budapest   (Hungary)

^d EÖTVÖS LORÁND UNIVERSITY   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVIN RECEPTOR LIKE KINASE 1; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 1; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 2; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 3; MESSENGER RNA;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN ISCHEMIA; BRAIN LEVEL; BRAIN REGION; CELL LEVEL; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE MARKER; ENDOTHELIUM CELL; MALE; MICROGLIA; MIDDLE CEREBRAL ARTERY OCCLUSION; MOLECULAR PATHOLOGY; NONHUMAN; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RAT; SIGNAL TRANSDUCTION; ANIMAL; BRAIN; DISEASE MODEL; GENE EXPRESSION REGULATION; GENETICS; IN SITU HYBRIDIZATION; ISCHEMIA; METABOLISM; NERVE CELL; PATHOLOGY; TIME; VASCULARIZATION;

RATTUS;

ANIMALS; BRAIN; DISEASE MODELS, ANIMAL; ENDOTHELIAL CELLS; GENE EXPRESSION REGULATION; IN SITU HYBRIDIZATION; ISCHEMIA; MALE; MICROGLIA; NEURONS; RATS; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; RNA, MESSENGER; TIME FACTORS;

EID: 84906996463     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0106544     Document Type: Article

References (81)

1. Weiss A, Attisano L (2013) The TGFbeta superfamily signaling pathway. Wiley Interdiscip Rev Dev Biol 2: 47-63.
2. Arighi CN, Liu H, Natale DA, Barker WC, Drabkin H, et al. (2009) TGF-beta signaling proteins and the Protein Ontology. BMC Bioinformatics 10 Suppl 5: S3.
3. Massague J, Chen YG (2000) Controlling TGF-beta signaling. Genes Dev 14: 627-644.
4. Huang F, Chen YG (2012) Regulation of TGF-beta receptor activity. Cell Biosci 2: 9.
5. Roberts AB (1998) Molecular and cell biology of TGF-beta. Miner Electrolyte Metab 24: 111-119.
6. Lawrence DA (1996) Transforming growth factor-beta: a general review. Eur Cytokine Netw 7: 363-374.
7. Wrighton KH, Lin X, Feng XH (2009) Phospho-control of TGF-beta superfamily signaling. Cell Res 19: 8-20.
8. Wrana JL, Attisano L, Wieser R, Ventura F, Massague J (1994) Mechanism of activation of the TGF-beta receptor. Nature 370: 341-347.
9. Bilandzic M, Stenvers KL (2012) Reprint of: Betaglycan: a multifunctional accessory. Mol Cell Endocrinol 359: 13-22.
10. Wang XF, Lin HY, Ng-Eaton E, Downward J, Lodish HF, et al. (1991) Expression cloning and characterization of the TGF-beta type III receptor. Cell 67: 797-805.
11. Blobe GC, Schiemann WP, Pepin MC, Beauchemin M, Moustakas A, et al. (2001) Functional roles for the cytoplasmic domain of the type III transforming growth factor beta receptor in regulating transforming growth factor beta signaling. J Biol Chem 276: 24627-24637.
12. Lewis KA, Gray PC, Blount AL, MacConell LA, Wiater E, et al. (2000) Betaglycan binds inhibin and can mediate functional antagonism of activin signalling. Nature 404: 411-414.
13. Lopez-Casillas F, Wrana JL, Massague J (1993) Betaglycan presents ligand to the TGF beta signaling receptor. Cell 73: 1435-1444.
14. Lux A, Attisano L, Marchuk DA (1999) Assignment of transforming growth factor beta1 and beta3 and a third new ligand to the type I receptor ALK-1. J Biol Chem 274: 9984-9992.
15. Goumans MJ, Valdimarsdottir G, Itoh S, Lebrin F, Larsson J, et al. (2003) Activin receptor-like kinase (ALK)1 is an antagonistic mediator of lateral TGFbeta/ALK5 signaling. Mol Cell 12: 817-828.
16. Unsicker K, Flanders KC, Cissel DS, Lafyatis R, Sporn MB (1991) Transforming growth factor beta isoforms in the adult rat central and peripheral nervous system. Neuroscience 44: 613-625.
17. Bottner M, Krieglstein K, Unsicker K (2000) The transforming growth factorbetas: structure, signaling, and roles in nervous system development and functions. J Neurochem 75: 2227-2240.
18. Popp A, Jaenisch N, Witte OW, Frahm C (2009) Identification of ischemic regions in a rat model of stroke. PLoS One 4: e4764.
19. Yamashita K, Gerken U, Vogel P, Hossmann K, Wiessner C (1999) Biphasic expression of TGF-beta1 mRNA in the rat brain following permanent occlusion of the middle cerebral artery. Brain Res 836: 139-145.
20. Pal G, Vincze C, Renner E, Wappler EA, Nagy Z, et al. (2012) Time course, distribution and cell types of induction of transforming growth factor betas following middle cerebral artery occlusion in the rat brain. PLoS One 7: e46731.
21. Dobolyi A, Vincze C, Pal G, Lovas G (2012) The neuroprotective functions of transforming growth factor Beta proteins. Int J Mol Sci 13: 8219-8258.
22. Mathieu P, Piantanida AP, Pitossi F (2011) Chronic expression of transforming growth factor-beta enhances adult neurogenesis. Neuroimmunomodulation 17: 200-201.
23. Vogel T, Ahrens S, Buttner N, Krieglstein K (2010) Transforming growth factor beta promotes neuronal cell fate of mouse cortical and hippocampal progenitors in vitro and in vivo: identification of Nedd9 as an essential signaling component. Cereb Cortex 20: 661-671.
24. Zhu Y, Yang GY, Ahlemeyer B, Pang L, Che XM, et al. (2002) Transforming growth factor-beta 1 increases bad phosphorylation and protects neurons against damage. J Neurosci 22: 3898-3909.
25. Gross CE, Bednar MM, Howard DB, Sporn MB, MacMillan V (1993) Transforming growth factor-β1 reduces infarct size after experimental cerebral ischemia in a rabbit model. Stroke 24: 558-562.
26. Prehn JH, Backhauss C, Krieglstein J (1993) Transforming growth factor-beta 1 prevents glutamate neurotoxicity in rat neocortical cultures and protects mouse neocortex from ischemic injury in vivo. J Cereb Blood Flow Metab 13: 521-525.
27. Ruocco A, Nicole O, Docagne F, Ali C, Chazalviel L, et al. (1999) A transforming growth factor-beta antagonist unmasks the neuroprotective role of this endogenous cytokine in excitotoxic and ischemic brain injury. J Cereb Blood Flow Metab 19: 1345-1353.
28. Akhurst RJ, Hata A (2012) Targeting the TGFbeta signalling pathway in disease. Nat Rev Drug Discov 11: 790-811.
29. Manaenko A, Lekic T, Barnhart M, Hartman R, Zhang JH (2014) Inhibition of Transforming Growth Factor-beta Attenuates Brain Injury and Neurological Deficits in a Rat Model of Germinal Matrix Hemorrhage. Stroke.
30. Slotkin TA, Wang XF, Symonds HS, Seidler FJ (1997) Expression of mRNAs coding for the transforming growth factor-beta receptors in brain regions of euthyroid and hypothyroid neonatal rats and in adult brain. Brain Res Dev Brain Res 99: 61-65.
31. De Groot CJ, Montagne L, Barten AD, Sminia P, Van Der Valk P (1999) Expression of transforming growth factor (TGF)-beta1, -beta2, and -beta3 isoforms and TGF-beta type I and type II receptors in multiple sclerosis lesions and human adult astrocyte cultures. J Neuropathol Exp Neurol 58: 174-187.
32. Ata KA, Lennmyr F, Funa K, Olsson Y, Terent A (1999) Expression of transforming growth factor-beta1, 2, 3 isoforms and type I and II receptors in acute focal cerebral ischemia: an immunohistochemical study in rat after transient and permanent occlusion of middle cerebral artery. Acta Neuropathol 97: 447-455.
33. Vivien D, Bernaudin M, Buisson A, Divoux D, MacKenzie ET, et al. (1998) Evidence of type I and type II transforming growth factor-beta receptors in central nervous tissues: changes induced by focal cerebral ischemia. J Neurochem 70: 2296-2304.
34. Li JJ, Lu J, Kaur C, Sivakumar V, Wu CY, et al. (2008) Effects of hypoxia on expression of transforming growth factor-beta1 and its receptors I and II in the amoeboid microglial cells and murine BV-2 cells. Neuroscience 156: 662-672.
35. MacConell LA, Leal AM, Vale WW (2002) The distribution of betaglycan protein and mRNA in rat brain, pituitary, and gonads: implications for a role for betaglycan in inhibin-mediated reproductive functions. Endocrinology 143: 1066-1075.
36. Oh SP, Seki T, Goss KA, Imamura T, Yi Y, et al. (2000) Activin receptor-like kinase 1 modulates transforming growth factor-beta 1 signaling in the regulation of angiogenesis. Proc Natl Acad Sci U S A 97: 2626-2631.
37. Garrido-Martin EM, Blanco FJ, Roque M, Novensa L, Tarocchi M, et al. (2013) Vascular injury triggers Kruppel-like factor 6 mobilization and cooperation with specificity protein 1 to promote endothelial activation through upregulation of the activin receptor-like kinase 1 gene. Circ Res 112: 113-127.
38. Konig HG, Kogel D, Rami A, Prehn JH (2005) TGF-{beta}1 activates two distinct type I receptors in neurons: implications for neuronal NF-{kappa}B signaling. J Cell Biol 168: 1077-1086.
39. Longa EZ, Weinstein PR, Carlson S, Cummins R (1989) Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 20: 84-91.
40. Paxinos G, Watson C (2005) The Rat Brain in Stereotaxic Coordinates. San Diego: Academic Press.
41. Seki T, Yun J, Oh SP (2003) Arterial endothelium-specific activin receptor-like kinase 1 expression suggests its role in arterialization and vascular remodeling. Circ Res 93: 682-689.
42. Ramos-Cabrer P, Campos F, Sobrino T, Castillo J (2011) Targeting the ischemic penumbra. Stroke 42: S7-S11.
43. Imai Y, Kohsaka S (2002) Intracellular signaling in M-CSF-induced microglia activation: role of Iba1. Glia 40: 164-174.
44. Townsend TA, Robinson JY, How T, DeLaughter DM, Blobe GC, et al. (2012) Endocardial cell epithelial-mesenchymal transformation requires Type III TGFbeta receptor interaction with GIPC. Cell Signal 24: 247-256.
45. Lee NY, Kirkbride KC, Sheu RD, Blobe GC (2009) The transforming growth factor-beta type III receptor mediates distinct subcellular trafficking and downstream signaling of activin-like kinase (ALK)3 and ALK6 receptors. Mol Biol Cell 20: 4362-4370.
46. Deng X, Bellis S, Yan Z, Friedman E (1999) Differential responsiveness to autocrine and exogenous transforming growth factor (TGF) beta1 in cells with nonfunctional TGF-beta receptor type III. Cell Growth Differ 10: 11-18.
47. Hawinkels LJ, Garcia de Vinuesa A, Ten Dijke P (2013) Activin receptor-like kinase 1 as a target for anti-angiogenesis therapy. Expert Opin Investig Drugs 22: 1371-1383.
48. Mabuchi T, Kitagawa K, Ohtsuki T, Kuwabara K, Yagita Y, et al. (2000) Contribution of microglia/macrophages to expansion of infarction and response of oligodendrocytes after focal cerebral ischemia in rats. Stroke 31: 1735-1743.
49. Schilling M, Besselmann M, Leonhard C, Mueller M, Ringelstein EB, et al. (2003) Microglial activation precedes and predominates over macrophage infiltration in transient focal cerebral ischemia: a study in green fluorescent protein transgenic bone marrow chimeric mice. Exp Neurol 183: 25-33.
50. Chao CC, Hu S, Sheng WS, Tsang M, Peterson PK (1995) Tumor necrosis factor-alpha mediates the release of bioactive transforming growth factor-beta in murine microglial cell cultures. Clin Immunol Immunopathol 77: 358-365.
51. da Cunha A, Jefferson JA, Jackson RW, Vitkovic L (1993) Glial cell-specific mechanisms of TGF-beta 1 induction by IL-1 in cerebral cortex. J Neuroimmunol 42: 71-85.
52. Morgan TE, Rozovsky I, Sarkar DK, Young-Chan CS, Nichols NR, et al. (2000) Transforming growth factor-beta1 induces transforming growth factor-beta1 and transforming growth factor-beta receptor messenger RNAs and reduces complement C1qB messenger RNA in rat brain microglia. Neuroscience 101: 313-321.
53. Bloom BB, Humphries DE, Kuang PP, Fine A, Goldstein RH (1996) Structure and expression of the promoter for the R4/ALK5 human type I transforming growth factor-beta receptor: regulation by TGF-beta. Biochim Biophys Acta 1312: 243-248.
54. Hempel N, How T, Cooper SJ, Green TR, Dong M, et al. (2008) Expression of the type III TGF-beta receptor is negatively regulated by TGF-beta. Carcinogenesis 29: 905-912.
55. Farnworth PG, Wang Y, Escalona R, Leembruggen P, Ooi GT, et al. (2007) Transforming growth factor-beta blocks inhibin binding to different target cell types in a context-dependent manner through dual mechanisms involving betaglycan. Endocrinology 148: 5355-5368.
56. Prehn JH, Peruche B, Unsicker K, Krieglstein J (1993) Isoform-specific effects of transforming growth factors-beta on degeneration of primary neuronal cultures induced by cytotoxic hypoxia or glutamate. J Neurochem 60: 1665-1672.
57. Zhou X, Spittau B, Krieglstein K (2012) TGFbeta signalling plays an important role in IL4-induced alternative activation of microglia. J Neuroinflammation 9: 210.
58. Gordon S (2003) Alternative activation of macrophages. Nat Rev Immunol 3: 23-35.
59. Tsunawaki S, Sporn M, Ding A, Nathan C (1988) Deactivation of macrophages by transforming growth factor-beta. Nature 334: 260-262.
60. Gehrmann J, Banati RB, Wiessner C, Hossmann KA, Kreutzberg GW (1995) Reactive microglia in cerebral ischaemia: an early mediator of tissue damage? Neuropathol Appl Neurobiol 21: 277-289.
61. Marin-Teva JL, Cuadros MA, Martin-Oliva D, Navascues J (2012) Microglia and neuronal cell death. Neuron Glia Biol: 1-16.
62. Xiao BG, Bai XF, Zhang GX, Link H (1997) Transforming growth factor-beta1 induces apoptosis of rat microglia without relation to bcl-2 oncoprotein expression. Neurosci Lett 226: 71-74.
63. Jones LL, Kreutzberg GW, Raivich G (1998) Transforming growth factor beta's 1, 2 and 3 inhibit proliferation of ramified microglia on an astrocyte monolayer. Brain Res 795: 301-306.
64. Gault J, Sarin H, Awadallah NA, Shenkar R, Awad IA (2004) Pathobiology of human cerebrovascular malformations: basic mechanisms and clinical relevance. Neurosurgery 55: 1-16; discussion 16-17.
65. Wick W, Naumann U, Weller M (2006) Transforming growth factor-beta: a molecular target for the future therapy of glioblastoma. Curr Pharm Des 12: 341-349.
66. van Meeteren LA, Thorikay M, Bergqvist S, Pardali E, Stampino CG, et al. (2012) Anti-human activin receptor-like kinase 1 (ALK1) antibody attenuates bone morphogenetic protein 9 (BMP9)-induced ALK1 signaling and interferes with endothelial cell sprouting. J Biol Chem 287: 18551-18561.
67. Albinana V, Sanz-Rodriguez F, Recio-Poveda L, Bernabeu C, Botella LM (2011) Immunosuppressor FK506 increases endoglin and activin receptor-like kinase 1 expression and modulates transforming growth factor-beta1 signaling in endothelial cells. Mol Pharmacol 79: 833-843.
68. Lagord C, Berry M, Logan A (2002) Expression of TGFbeta2 but not TGFbeta1 correlates with the deposition of scar tissue in the lesioned spinal cord. Mol Cell Neurosci 20: 69-92.
69. Schachtrup C, Ryu JK, Helmrick MJ, Vagena E, Galanakis DK, et al. (2010) Fibrinogen triggers astrocyte scar formation by promoting the availability of active TGF-beta after vascular damage. J Neurosci 30: 5843-5854.
70. Flanders KC, Ludecke G, Engels S, Cissel DS, Roberts AB, et al. (1991) Localization and actions of transforming growth factor-βs in the embryonic nervous system. Development 113: 183-191.
71. Yin J, Sakamoto K, Zhang H, Ito Z, Imagama S, et al. (2009) Transforming growth factor-beta1 upregulates keratan sulfate and chondroitin sulfate biosynthesis in microglias after brain injury. Brain Res 1263: 10-22.
72. Flanders KC, Ren RF, Lippa CF (1998) Transforming growth factor-betas in neurodegenerative disease. Prog Neurobiol 54: 71-85.
73. Dhandapani KM, Brann DW (2003) Transforming growth factor-beta: a neuroprotective factor in cerebral ischemia. Cell Biochem Biophys 39: 13-22.
74. Chopp M, Li Y (1996) Apoptosis in focal cerebral ischemia. Acta Neurochir Suppl 66: 21-26.
75. Guegan C, Sola B (2000) Early and sequential recruitment of apoptotic effectors after focal permanent ischemia in mice. Brain Res 856: 93-100.
76. Namura S, Zhu J, Fink K, Endres M, Srinivasan A, et al. (1998) Activation and cleavage of caspase-3 in apoptosis induced by experimental cerebral ischemia. J Neurosci 18: 3659-3668.
77. Sharp FR, Lu A, Tang Y, Millhorn DE (2000) Multiple molecular penumbras after focal cerebral ischemia. J Cereb Blood Flow Metab 20: 1011-1032.
78. Barone FC (2010) Post-stroke pharmacological intervention: Promoting brain recovery from injury in the future. Neuropharmacology 59: 650-653.
79. Feng Z, Ko CP (2008) Schwann cells promote synaptogenesis at the neuromuscular junction via transforming growth factor-beta1. J Neurosci 28: 9599-9609.
80. Unsicker K, Meier C, Krieglstein K, Sartor BM, Flanders KC (1996) Expression, localization, and function of transforming growth factor-beta s in embryonic chick spinal cord, hindbrain, and dorsal root ganglia. J Neurobiol 29: 262-276.
81. Abe K, Chu PJ, Ishihara A, Saito H (1996) Transforming growth factor-beta 1 promotes re-elongation of injured axons of cultured rat hippocampal neurons. Brain Res 723: 206-209.